比亞迪(01211.HK)和吉利奪以色列電動車銷量冠、亞軍
以色列汽車進口商協會數據顯示,比亞迪(01211.HK)和吉利汽車集團分別奪得去年以色列電動車銷量冠、亞軍。
比亞迪跨界SUV Atto3成為去年以色列最暢銷電動車,銷量為14,244輛。同期,比亞迪其他電動車型在以銷量為901輛。比亞迪不僅是去年以色列最暢銷電動汽車品牌,同時也是以色列第四大暢銷汽車品牌。
吉利汽車集團幾何C車型奪得去年以色列電動汽車銷量亞軍,銷量為7,129輛。美國汽車製造商Tesla(TSLA.US)和南韓現代汽車分別在以售出6,767輛和4,424輛電動汽車,位列銷量榜的第三及第四。
去年中國電動車在以色列的總銷量為29,402輛,是2022年的兩倍多,佔以色列電動車市場份額60.98%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.